Product Information
GNP IBUPROFEN 200 MG MINI SFGL is a generic product labeled by AmerisourceBergen, priced at $0.0762 per EA under NDC 46122059341. Its NADAC has been published 198 times since Dec 21, 2022.
FDA first approved this application on Mar 24, 2009.
Strength
200 mg/1
Manufacturer
AmerisourceBergenNDC
46122059341
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA078682FDA Approved
3/24/2009
On Market Since
3/1/2019
Pharmacological Classes
Price Statistics
The NADAC for GNP IBUPROFEN 200 MG MINI SFGL has been published 198 times since Dec 21, 2022, and over the history we have for it it has declined 12.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0762 per EA |
|---|---|
| All-time high | $0.0979 (Feb 15, 2023) |
| All-time low | $0.0742 (Apr 17, 2024) |
| 52-week high | $0.0816 |
| 52-week low | $0.0762 |
| Median price | $0.0800 |
| Average price | $0.0811 |
| Largest weekly change | -13.4% (Feb 22, 2023) |
| Weeks tracked | 198 |
| Tracking since | Dec 21, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ibuprofen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP IBUPROFEN 200 MG MINI SFGL?
The current National Average Drug Acquisition Cost (NADAC) for GNP IBUPROFEN 200 MG MINI SFGL, manufactured by AmerisourceBergen, is $0.0762 per EA (NDC 46122059341), effective Sep 30, 2026.
How has the price of GNP IBUPROFEN 200 MG MINI SFGL changed over time?
Over the history we have for it, the NADAC for GNP IBUPROFEN 200 MG MINI SFGL has declined 12.7%. It has been tracked across 198 weekly CMS publications since Dec 21, 2022.
What are the highest and lowest recorded NADAC prices for GNP IBUPROFEN 200 MG MINI SFGL?
Since Dec 21, 2022, the NADAC for GNP IBUPROFEN 200 MG MINI SFGL has ranged from a low of $0.0742 (Apr 17, 2024) to a high of $0.0979 (Feb 15, 2023), with a median of $0.0800 per EA.
Are there cheaper alternatives to GNP IBUPROFEN 200 MG MINI SFGL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as GNP IBUPROFEN 200 MG MINI SFGL in a comparable dosage form, but none are currently priced below it.
Who manufactures GNP IBUPROFEN 200 MG MINI SFGL?
GNP IBUPROFEN 200 MG MINI SFGL (NDC 46122059341) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.